These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 20554347

  • 1. Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant.
    Schmidt PW, Hirschl MM, Trautinger F.
    J Am Acad Dermatol; 2010 Nov; 63(5):913-4. PubMed ID: 20554347
    [No Abstract] [Full Text] [Related]

  • 2. [Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor].
    Fast S, Henningsen E, Bygum A.
    Ugeskr Laeger; 2011 Oct 10; 173(41):2574-5. PubMed ID: 21985837
    [Abstract] [Full Text] [Related]

  • 3. Bradykinin-receptor antagonist icatibant: possible treatment for ACE inhibitor-related angio-oedema.
    Manders K, van Deuren M, Hoedemaekers C, Simon A.
    Neth J Med; 2012 Oct 10; 70(8):386-7. PubMed ID: 23065991
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors.
    Gallitelli M, Alzetta M.
    Am J Emerg Med; 2012 Oct 10; 30(8):1664.e1-2. PubMed ID: 22100478
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Icatibant and ACE inhibitor angioedema.
    Illing EJ, Kelly S, Hobson JC, Charters S.
    BMJ Case Rep; 2012 Aug 30; 2012():. PubMed ID: 22936825
    [Abstract] [Full Text] [Related]

  • 12. [Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].
    Bas M, Kojda G, Stelter K.
    Anaesthesist; 2011 Dec 30; 60(12):1141-5. PubMed ID: 20922352
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
    Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W.
    J Allergy Clin Immunol; 2007 Jun 30; 119(6):1497-503. PubMed ID: 17418383
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin-converting enzyme inhibitor-induced angioedema and icatibant: a new hope.
    Jacob J, Bardes I, Palom X, Carrizosa M, Fuentes E.
    Intern Med J; 2015 Oct 30; 45(10):1093-4. PubMed ID: 26429224
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema.
    Sinert R, Levy P, Bernstein JA, Body R, Sivilotti MLA, Moellman J, Schranz J, Baptista J, Kimura A, Nothaft W, CAMEO study group.
    J Allergy Clin Immunol Pract; 2017 Oct 30; 5(5):1402-1409.e3. PubMed ID: 28552382
    [Abstract] [Full Text] [Related]

  • 19. Commentary regarding: A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
    Yancey KB.
    Dermatol Ther; 2015 Oct 30; 28(5):331. PubMed ID: 25818322
    [No Abstract] [Full Text] [Related]

  • 20. Icatibant in ACE-inhibitor-induced angioedema.
    Tomkiewicz W.
    N Engl J Med; 2015 May 07; 372(19):1866. PubMed ID: 25946292
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.